Multi-Cancer Early Detection Test

At Duly Health and Care, we know that the ear­li­er can­cer is found, the more choic­es patients may have for treat­ment and the bet­ter the poten­tial out­comes. While tra­di­tion­al screen­ings like mam­mo­grams, colono­scopies, and skin checks are essen­tial, they only cov­er a lim­it­ed num­ber of can­cers. Many oth­er can­cers don’t have rec­om­mend­ed screen­ing tests, which means they’re often dis­cov­ered at lat­er stages.

That’s why we are now offer­ing access to the Gal­leri® mul­ti-can­cer ear­ly detec­tion test. With a sin­gle blood draw, the Gal­leri test screens for a sig­nal shared by more than 50 types of can­cer, iden­ti­fy­ing can­cers before you may even expe­ri­ence symptoms.

Book a pri­ma­ry care appoint­ment to request an MCED Test

What is a Mul­ti-Can­cer Ear­ly Detec­tion (MCED) Test?

A Mul­ti-Can­cer Ear­ly Detec­tion (MCED) test is a new type of screen­ing tool that looks for a shared ​“sig­nal” from many dif­fer­ent can­cers in your blood. By iden­ti­fy­ing abnor­mal DNA that may be released by can­cer cells, the Gal­leri test can help find can­cers that are often missed until symp­toms appear.

The Gal­leri test has been shown to detect sig­nals asso­ci­at­ed with more than 50 types of can­cer, including:

• Can­cers with exist­ing screen­ing options: breast, cer­vi­cal, col­orec­tal, lung, and prostate
  *Note, this test does not replace and is used in addi­tion to rec­om­mend­ed screen­ings such as mam­mo­grams, colono­scopies, pap smears, and lung and prostate screenings.

• Can­cers with­out rou­tine screen­ing options: pan­cre­at­ic, ovar­i­an, esophageal, liv­er, kid­ney, stom­ach, and others

The Gal­leri test iden­ti­fies DNA in the blood­stream shed by can­cer cells and does not pre­dict future genet­ic risk for can­cer. Gal­leri is a screen­ing test and does not diag­nose can­cer. Diag­nos­tic test­ing is need­ed to con­firm cancer.

How does an MCED Test work? 

Watch this video on how the Gal­leri test works > 

Who should get an MCED Test?

The Gal­leri test is rec­om­mend­ed for adults 50 years and old­er or those with a high­er risk of can­cer. It is used in addi­tion to rec­om­mend­ed screen­ings such as mam­mo­grams or colonoscopies.

MCED tests are avail­able by pre­scrip­tion only. This test is not rec­om­mend­ed for indi­vid­u­als who are preg­nant, under 21, or under­go­ing active can­cer treatment. 

How much does the MCED Test cost? 

The Gal­leri test is avail­able as a $749 cash-pay option for Duly patients or is cov­ered by TRI­CARE® health plans for eli­gi­ble patients ages 50 and up. Patients may be able to use pre­tax dol­lars in their flex­i­ble spend­ing account (FSA) or health sav­ings account (HSA) to pay for the Gal­leri test. Patients should check with their FSA/HSA admin­is­tra­tor or insur­ance provider to deter­mine eligibility. 

Take an MCED Test 

Sched­ule a check-up with your pri­ma­ry care provider to dis­cuss a mul­ti-can­cer ear­ly detec­tion test today > 

If your provider orders the Gal­leri MCED test, you can walk-in to any of our Duly lab clin­ics for your sim­ple blood draw. 

Your results will be shared in your MyChart account and with your provider about four weeks after your blood draw. If the test iden­ti­fies a can­cer sig­nal, your provider will walk you through addi­tion­al diag­nos­tic test­ing, con­nect­ing you with our expert can­cer care team.  

View all impor­tant safe­ty infor­ma­tion from Gal­leri: https://​www​.gal​leri​.com/​s​a​f​e​t​y​-​i​n​f​o​r​m​ation